» Articles » PMID: 30760516

Mapping of Modifiable Barriers and Facilitators of Medication Adherence in Bipolar Disorder to the Theoretical Domains Framework: a Systematic Review Protocol

Overview
Journal BMJ Open
Specialty General Medicine
Date 2019 Feb 15
PMID 30760516
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: People with bipolar disorder require long-term treatment but it is estimated that 40% of these people do not adhere to prescribed medication regimens. Non-adherence increases the risk of relapse, hospitalisation and suicide. Some evidence syntheses report barriers to mental health treatment adherence but rarely delineate between modifiable and non-modifiable barriers. They also fail to distinguish between the patients' perspective and that of other stakeholders such as clinicians despite of their different understanding and priorities about adherence. Facilitators of adherence, which are also important for informing adherence intervention design, are also lacking from syntheses and few syntheses focus on medications for bipolar disorder.This systematic review aims to identify modifiable barriers and facilitators (determinants) of medication adherence in bipolar disorder. We also plan to report determinants of medication adherence from perspectives of patients, carers, healthcare professionals and other third parties. A unique feature of this systematic review in the context of mental health is the use of the Theoretical Domains Framework (TDF) to organise the literature identified determinants of medication adherence.

Methods And Analysis: The protocol adheres to Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols and ENhancing Transparency in REporting the synthesis of Qualitative research (ENTREQ) guidelines. This review will include both qualitative and quantitative primary studies exploring determinants of medication adherence in bipolar disorder. We will search the following databases using a preplanned strategy: CINAHL, Cochrane Library (CENTRAL), Embase, LiLACS, Medline, PsychINFO, PubMed without date restrictions. We will report the quality of included studies. We will use framework synthesis using the TDF as an a priori 'framework'. We will map the literature identified modifiable determinants to the domains of TDF.

Ethics And Dissemination: Ethical approval is not required as primary data will not be collected. The results will be disseminated through a peer-reviewed publication.

Prospero Registration Number: CRD42018096306.

Citing Articles

Behavioral factors associated with medication adherence among hypertensive patients using the theoretical domains framework.

De Tran V, Vo T, Vo Q, Nguyen M, Nguyen M, Dewey R Explor Res Clin Soc Pharm. 2024; 16:100510.

PMID: 39399764 PMC: 11470627. DOI: 10.1016/j.rcsop.2024.100510.


Adherence to Parkinson's disease medication: A case study to illustrate reasons for non-adherence, implications for practice and engaging under-represented participants in research.

James D, Smith J, Lane E, Thomas R, Brown S, Seage H Explor Res Clin Soc Pharm. 2024; 14:100450.

PMID: 38800618 PMC: 11127522. DOI: 10.1016/j.rcsop.2024.100450.


Using the theoretical domains framework to determine the barriers and facilitators to medication adherence in Parkinson's disease.

Smith J, Seage C, Lane E, James D Explor Res Clin Soc Pharm. 2023; 11:100309.

PMID: 37583935 PMC: 10423922. DOI: 10.1016/j.rcsop.2023.100309.


"We want to live a little longer and our family want[s] us around": A summative content analysis of adherence to COVID-19-related guidelines using the Theoretical Domains Framework.

Leather J, Keyworth C, Epton T, Goldthorpe J, Ulph F, Armitage C Br J Health Psychol. 2022; 27(3):1119-1152.

PMID: 35319141 PMC: 9111475. DOI: 10.1111/bjhp.12591.


Barriers and facilitators to the implementation of osteoarthritis management programmes in primary or community care settings: a systematic review and qualitative framework synthesis protocol.

Cunningham J, Briggs A, Cottrell E, Doyle F, Dziedzic K, Finney A HRB Open Res. 2021; 4:102.

PMID: 34746643 PMC: 8543168. DOI: 10.12688/hrbopenres.13377.1.


References
1.
de Geest S, Sabate E . Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs. 2003; 2(4):323. DOI: 10.1016/S1474-5151(03)00091-4. View

2.
Tong A, Flemming K, Mcinnes E, Oliver S, Craig J . Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol. 2012; 12:181. PMC: 3552766. DOI: 10.1186/1471-2288-12-181. View

3.
Katrak P, Bialocerkowski A, Massy-Westropp N, Kumar S, Grimmer K . A systematic review of the content of critical appraisal tools. BMC Med Res Methodol. 2004; 4:22. PMC: 521688. DOI: 10.1186/1471-2288-4-22. View

4.
Velligan D, Weiden P, Sajatovic M, Scott J, Carpenter D, Ross R . The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009; 70 Suppl 4:1-46. View

5.
Grunze H, Vieta E, Goodwin G, Bowden C, Licht R, Moller H . The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013; 14(3):154-219. DOI: 10.3109/15622975.2013.770551. View